Jennifer L. Beck

Pediatrics

801 7th Ave
Fort Worth, TX 76104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5 publications

Outcomes of patients with or without DNA repair pathway alterations: the MD Anderson IMPACT2 study.

Outcomes of patients with or without DNA repair pathway alterations: the MD Anderson IMPACT2 study.

Journal: NPJ precision oncology

Published: December 10, 2025

Concordance analysis of DNA and RNA profiling: The MD Anderson IMPACT2 study in precision oncology.

Concordance analysis of DNA and RNA profiling: The MD Anderson IMPACT2 study in precision oncology.

Journal: Signal transduction and targeted therapy

Published: August 12, 2025

First-in-Human Study of OBI-999, a Globo H-Targeting Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors.

First-in-Human Study of OBI-999, a Globo H-Targeting Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors.

Journal: JCO precision oncology

Published: January 26, 2023

Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer.

Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer.

Journal: Cancer immunology research

Published: September 01, 2022

Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology.

Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology.

Journal: NPJ precision oncology

Published: May 24, 2022

Showing 1-5 of 5

Last Updated: 09/26/2026